scholarly journals PARP Inhibitors in Pancreatic Cancer: From Phase I to Plenary Session

2019 ◽  
Vol 3 (1) ◽  
pp. e5-e8 ◽  
Author(s):  
Rajvi Patel ◽  
◽  
Daniel Fein ◽  
Carolina B. Ramirez ◽  
Kevin Do ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Plenary Session ◽  
Parp Inhibitors

PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer

2021 ◽  
Vol 38 (6) ◽  
Author(s):  
Devashish Desai ◽  
Pushti Khandwala ◽  
Meghana Parsi ◽  
Rashmika Potdar
Keyword(s):  
Pancreatic Cancer ◽  
Parp Inhibitors

Gemcitabine (G) in combination radiationtherapy (RT) in stage III–IV pancreatic cancer: first results of a current phase I study

1999 ◽  
Vol 35 ◽  
pp. S148 ◽  
Author(s):  
U. Maurer ◽  
P. Stegmeier ◽  
R. Bolte ◽  
K.P. Jungius ◽  
D. Mueller ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Stage Iii ◽  
Current Phase ◽  
First Results ◽  
A Current

A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer

2014 ◽  
Vol 74 (5) ◽  
pp. 911-915 ◽  
Author(s):  
Yousuke Nakai ◽  
Hiroyuki Isayama ◽  
Kei Saito ◽  
Takashi Sasaki ◽  
Naminatsu Takahara ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Advanced Pancreatic Cancer

Phase I Trials in Pancreatic Cancer

2020 ◽  
pp. 219-232
Author(s):  
Thomas Seufferlein ◽  
Angelika Kestler ◽  
Alica Beutel ◽  
Lukas Perkhofer ◽  
Thomas Ettrich
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Phase I Trials
Sign in / Sign up

Export Citation Format

Share Document